Understanding Your Child's Isolated Lateralized Overgrowth (ILO)
At a Glance
Isolated Lateralized Overgrowth (ILO), formerly hemihyperplasia, causes asymmetrical growth in a child's limbs. Children face a temporary increased risk of kidney and liver tumors until age 8, which is effectively managed with routine abdominal ultrasounds every three months.
It is completely natural to feel overwhelmed when you first hear that your child has a condition you may have never heard of. You might have seen different names in medical records—Isolated Hemihyperplasia (IHH) or Isolated Lateralized Overgrowth (ILO)—and wondered if they are the same thing. They are, and the shift in language reflects the medical community’s growing understanding of how your child’s body grows [1][2].
Understanding the Name Change
For many years, doctors used the term hemihyperplasia (from “hemi” meaning half and “hyperplasia” meaning overgrowth) [1]. However, this term was often technically incorrect because most children do not have overgrowth of an entire “half” of their body; instead, it might be just one leg, one arm, or even a specific segment like a finger [2].
The medical community transitioned to Isolated Lateralized Overgrowth (ILO) for several reasons:
- Precision: “Lateralized overgrowth” accurately describes growth on one side of the body without assuming how much of that side is involved [1][3].
- Identifying the Cause: The word “isolated” means the overgrowth is happening on its own, without other symptoms like heart defects or intellectual disabilities [2][4].
- Avoiding Assumptions: Older terms often incorrectly assumed that the cells were just larger (hypertrophy), when in many cases there are actually more cells (hyperplasia) [1].
What is Overgrowing?
In a child with ILO, the asymmetry typically involves all layers of the affected area. This includes:
- Bone: The bones on the affected side may be longer or thicker [2].
- Muscle: Muscle mass can appear more prominent on one side [5].
- Subcutaneous Fat: The layer of fat just beneath the skin can be thicker [5][2].
Because all these tissues are involved, the overgrowth is often most noticeable in the limbs (arms or legs), where it can lead to a limb length discrepancy (one leg being longer than the other) [6][2].
Three Stabilizing Facts for Parents
If you are newly navigating this diagnosis, these three facts can help ground your family’s approach to care:
- The Risk is Time-Limited: While ILO is associated with a higher risk (approximately 5-8% overall) of certain childhood tumors—specifically Wilms tumor (kidney) and hepatoblastoma (liver)—this risk is almost entirely concentrated in early childhood [7][8][9]. By the time your child reaches age 7 or 8, their risk returns to that of the general population [7][9].
- Screening is Highly Effective: Because doctors know exactly which tumors to look for and when they appear, there is a standardized “safety net” in place. Regular abdominal ultrasounds (usually every 3 months until age 7) are excellent at catching issues early when they are most treatable [3][9].
- Physical Growth is Manageable: Most children with ILO live active, typical lives. Asymmetries in leg length are often managed with simple shoe lifts. If the difference becomes more significant as they grow toward puberty, straightforward, minimally invasive orthopedic procedures (like epiphysiodesis, which briefly slows growth in the longer limb) can help equalize their height [10][11].
Clarifying the “Syndrome” Confusion
You may read that ILO is part of the Beckwith-Wiedemann Spectrum (BWSp) [6][12]. This can be deeply confusing—does your child have a syndrome or not?
While ILO falls under the genetic umbrella of the BWS spectrum (meaning they share a similar genetic root), the word “isolated” means your child is highly unlikely to develop the multi-organ, systemic issues seen in classic BWS [1][4]. ILO is a physical growth pattern. It is not a broad syndrome that affects cognitive development or overall internal health [1].
Who is on My Child’s Medical Team?
Navigating ILO requires a coordinated team of specialists. Typically, your child’s care “roster” will include:
- Pediatrician: The “quarterback” who oversees general health and coordinates referrals.
- Pediatric Geneticist / Genetic Counselor: To perform specialized tissue testing (like buccal swabs) and determine the exact genetic cause, which dictates the screening schedule [13][6].
- Pediatric Oncologist: Even if your child does not have cancer, oncologists often manage the ultrasound screening protocols because they are the experts in tumor surveillance [14].
- Pediatric Orthopedic Surgeon: To monitor limb length differences and spinal alignment as your child grows [9][11].
Common questions in this guide
Is isolated lateralized overgrowth the same as Beckwith-Wiedemann Syndrome?
What types of tumors are children with ILO at risk for?
How is the tumor risk managed for a child with ILO?
How do you treat limb length differences caused by ILO?
Why did the name change from isolated hemihyperplasia to ILO?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Has my child been tested for Beckwith-Wiedemann Spectrum or PIK3CA-related overgrowth to ensure this is truly 'isolated'?
- 2.What is the specific screening schedule (ultrasounds and blood tests) we should follow, and until what age?
- 3.Which tissues—bone, muscle, or fat—seem to be most involved in my child's asymmetry?
- 4.At what point should we consult a pediatric orthopedist for limb length monitoring?
- 5.If we notice a new lump or sudden change in the overgrowth, who is our first point of contact?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (14)
- 1
Nomenclature and definition in asymmetric regional body overgrowth.
Kalish JM, Biesecker LG, Brioude F, et al.
American journal of medical genetics. Part A 2017; (173(7)):1735-1738 doi:10.1002/ajmg.a.38266.
PMID: 28475229 - 2
Isolated lateralized overgrowth and the need for tumor screening: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Erwin AL, El Haija AA, Bennett JT, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2025; (27(10)):101480 doi:10.1016/j.gim.2025.101480.
PMID: 40693985 - 3
Isolated lateralized overgrowth: clinical, radiological, and auxological characteristics of a single-site cohort of 76 cases.
Romaris MJ, Caino S, Adamo P, Fano V
Archivos argentinos de pediatria 2022; (120(6)):405-414 doi:10.5546/aap.2022.eng.405.
PMID: 36374059 - 4
Evolution over Time of Leg Length Discrepancy in Patients with Syndromic and Isolated Lateralized Overgrowth.
Carli D, De Pellegrin M, Franceschi L, et al.
The Journal of pediatrics 2021; (234()):123-127 doi:10.1016/j.jpeds.2021.01.020.
PMID: 33465347 - 5
Muscle hemihypertrophy syndrome with PIK3CA gene mutation associated with Tourette syndrome.
Hayoun-Vigouroux M, Audebert S, Vabres P, et al.
JAAD case reports 2022; (30()):128-130 doi:10.1016/j.jdcr.2022.10.025.
PMID: 36457938 - 6
Prospective study of epigenetic alterations responsible for isolated hemihyperplasia/hemihypoplasia and their association with leg length discrepancy.
Shin CH, Lim C, Kim HY, et al.
Orphanet journal of rare diseases 2021; (16(1)):418 doi:10.1186/s13023-021-02042-6.
PMID: 34627330 - 7
Sonographic screening for Wilms tumor in children with CLOVES syndrome.
Peterman CM, Fevurly RD, Alomari AI, et al.
Pediatric blood & cancer 2017; (64(12)) doi:10.1002/pbc.26684.
PMID: 28627003 - 8
The following 3 cases were presented at the 2020 virtual PUOWG conferenceLate Presentation of Wilms Tumor in a Patient with Hemihypertrophy after Normal Screening.
Fischer KM, Mittal S, Long CJ, et al.
Urology 2021; (154()):271-274 doi:10.1016/j.urology.2021.01.054.
PMID: 33581236 - 9
Isolated Hemihyperplasia in Adolescence: A Case Report.
Solano R, Gomez K, Solano D, et al.
Cureus 2025; (17(8)):e90189 doi:10.7759/cureus.90189.
PMID: 40959375 - 10
Gait asymmetries in children and adolescents with mild leg length discrepancy.
Dobler F, Ender J, Lengnick H, Alexander N
Gait & posture 2026; (125()):109960 doi:10.1016/j.gaitpost.2025.08.078.
PMID: 40908220 - 11
Growth Deceleration for Limb Length Discrepancy: Tension Band Plates Followed to Maturity.
Stevens P, Desperes M, McClure PK, et al.
Strategies in trauma and limb reconstruction 2022; (17(1)):26-31 doi:10.5005/jp-journals-10080-1548.
PMID: 35734037 - 12
Tissue variations of mosaic genome-wide paternal uniparental disomy and phenotype of multi-syndromal congenital hyperinsulinism.
Christesen HT, Christensen LG, Löfgren ÅM, et al.
European journal of medical genetics 2020; (63(1)):103632 doi:10.1016/j.ejmg.2019.02.004.
PMID: 30797057 - 13
Investigation of 11p15.5 Methylation Defects Associated with Beckwith-Wiedemann Spectrum and Embryonic Tumor Risk in Lateralized Overgrowth Patients.
Tüysüz B, Bozlak S, Uludağ Alkaya D, et al.
Cancers 2023; (15(6)) doi:10.3390/cancers15061872.
PMID: 36980758 - 14
Fifteen-minute consultation: Assessment, surveillance and management of hemihypertrophy.
Mark C, Hart C, McCarthy A, Thompson A
Archives of disease in childhood. Education and practice edition 2018; (103(3)):114-117 doi:10.1136/archdischild-2017-312645.
PMID: 28844056
This page provides educational information about Isolated Lateralized Overgrowth (ILO). Always consult your child's pediatrician, geneticist, or oncologist for personalized screening schedules and medical advice.
Get notified when new evidence is published on Isolated hemihyperplasia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.